Can-Fite BioPharma Ltd. (CANF) Technical Analysis
Updated: 2026-05-01 03:14 UTC · Last close: 3.19 (+6.69%) · Resistance: 3.51
Can-Fite BioPharma Ltd. (CANF) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
⬆️ Resistance
3.51
Quick Read
Upside checkpoint: reclaiming 3.51 on a clean close would materially improve the chart.
🔺 Technical Setup
RSI(14)
51.8
📊 Technical Summary
The latest close for Can-Fite BioPharma Ltd. (CANF) came in at 3.19 (+6.69%). The chart is still trading below both the 50-day and 200-day moving averages, leaving the overall technical backdrop under pressure for now. 20-day momentum is positive at +3.24%; price is trading in the lower part of its roughly 52-week range (2.91–23.00); and ATR14 volatility is elevated at roughly 7.41% of price. RSI(14) stands around 51.8, which keeps the momentum picture broadly balanced. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram is positive and expanding, pointing to improving upside momentum. Recent trading volume is running well above its 20-day average, which suggests strong participation behind the latest price moves. On the upside, 3.51 is the nearest resistance area. A cleaner push through that zone would improve continuation potential. Fundamentals snapshot: Revenue: 202,000 · Net income: -4.88M. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.
💼 Fundamentals Snapshot
Source: sec
Company
Can-Fite BioPharma Ltd.
CIK (SEC ID)
0001536196
Shares Out.
3.97B
Revenue
202,000
Net Income
-4.88M
EPS (Basic)
0.00
Explore more
Note: This is an algorithmic technical snapshot (not financial advice).